Heart failure & cardiomyopathiesGuideline or statement
State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases
- Scientific statement
Scope
As issued by the authors
Overview of gene therapy modalities for HF and some of its risk factors, their clinical application, hereditary heart diseases and (non)-genetic HF, safety, clinical trial design and future regulatory strategies
Original publication
State of the Art and Perspectives of Gene Therapy in Heart Failure. A Scientific Statement of the Heart Failure Association of the ESC, the ESC Council on Cardiovascular Genomics and the ESC Working Group on Myocardial & Pericardial Diseases. Eur J Heart Fail. Published 22 November 2024. doi:10.1002/ejhf.3516
Summarised from the published abstract; every number is checked against it